OncoC4 Announces First Patient Dosing in Phase 1 Clinical Trial of ONC-783 for t...
— ONC-783 is the first-and-only clinical-stage T-cell engager targeting a cancer-specific glycoform of CD24 (neoCD24) ...
— ONC-783 is the first-and-only clinical-stage T-cell engager targeting a cancer-specific glycoform of CD24 (neoCD24) ...
He said early detection through advanced technologies and precision treatment would significantly improve patient outcom...
Biological defenses make losing weight and keeping it off unusually difficult. Better treatments, healthier environments...
Prateek Yadav, son of late Samajwadi Party founder Mulayam Singh Yadav, was reportedly battling a serious lung-related i...
(MENAFN - IANS) Islamabad, April 24 (IANS) Pakistan's treatment of religious minorities, particularly Sikh and Hindu wom...
Confused between IUI, IVF, and ICSI? Experts explain key differences, success rates, costs, and who each fertility treat...
In Kanha Wadi village, a healer named Babulal is making waves with his unique approach to treating cancer and other seri...
Some configurations of Mac mini and Mac Studio aren't available in Apple's online store. It's an indicator that a deskto...
Image for representation purposes only
The two-day scientific programme will feature international faculty from seven countries alongside leading Indian expert...